Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today congratulates its ...

Genflow Biosciences Provides Half Year Corporate Update on SIRT6 Programs, IP Progress and Strategic Partnerships LONDON, UK / ACCESS Newswire / June 17, 2025 / Genflow Biosciences Plc ...

A new featurette possibly hints at the arrival of a secret villain in Marvel's upcoming Ironheart series. Known for his ties ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The efforts of CNIC and CMIE are setting the stage for this future, ensuring that Canada remains at the cutting edge of ...

On June 10, 2025, the Commissioner of the FDA, Dr. Martin Makary, and Dr. Vinayak Prasad, the Director of the FDA’s Center ...

A growth-focused fund blending momentum and strong earnings. High upside potential with elevated volatility. Best for ...

NEW YORK, June 16, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global land ...

Oxford-based analytical instrument company Refeyn has announced a change in its board leadership, with Jonathan Flint stepping down as Chairman after six years. Flint, who has overseen a period ...

The metro's elected officials, stakeholders and academics weigh in on what Des Moines needs to do to stay on the right track.